ArticleJournal of translational medicine2025
Compositional data modeling of high-dimensional single cell RNA-seq (CoDA-hd): its advantages over commonly used normalization approaches.
Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transcriptomic Analysis Reveals PACS1 as a Potential Shared Candidate Biomarker for Apical Periodontitis and Osteoporosis.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCompositional data analysis (CoDA) is an emerging statistical framework and has been extended to microbiome, bulk RNA-seq, and cell type proportions in single-cell RNA-seq (scRNA-seq), which typically has 50-200 components. Here, we explore the high-dimensional application of CoDA (CoDA-hd) and its various log-ratio (LR) transformations to raw count matrix of scRNA-seq which has over 20,000 components (e.g., protein coding genes). scRNA-seq matrices are typically sparse and high-dimensional. Common approaches of normalization such as log-normalization may lead to suspicious findings as previously shown for trajectory inference. Although RNA-seq is compositional data by nature, the geometry of CoDA in high-dimensional simplex is not compatible with most downstream analyses of scRNA-seq which are based on Euclidean space. In this study, we attempted to explore: (1) CoDA adaptability to scRNA-seq; (2) handling of zero data: prior-log-normalization, imputation or with specific count addition scheme; (3) transformation to Euclidean space and compatibility with downstream analyses.
resultsOur results suggest that (1) the innovative count addition schemes (e.g., SGM) enable the application of CoDA to high dimensional sparse data (i.e., scRNA-seq); (2) log-normalized data could be transformed to CoDA LR representation; (3) CoDA LR transformations such as count-added centered-log-ratio (CLR) had some advantages in dimension reduction visualization, clustering, and trajectory inference in the tested real and simulated datasets. CLR provided more distinct and well-separated clusters in dimension reductions, improved the Slingshot trajectory inference, and eliminated the suspicious trajectory that was probably caused by the dropouts.
conclusionsWe therefore conclude that CoDA may be a preferred scale-free model to handle scRNA-seq data for these downstream tasks. Additionally, an R package 'CoDAhd' was developed for conducting CoDA LR transformations for high dimensional scRNA-seq data. The code for implementing CoDA-hd, along with some example datasets, are available at https://github.com/GO3295/CoDAhd .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.